Skip to content

Drug interactions

Memantine-donepezil + Mobocertinib

Severity: Major

Memantine-donepezil and Mobocertinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mobocertinib carries a boxed warning for QT prolongation and torsades de pointes, and donepezil adds further QT risk. The combination can cause life-threatening arrhythmia.

What this interaction means in plain words

Memantine-donepezil and Mobocertinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive QT interval prolongation.

What to do

Avoid concomitant use where possible. If unavoidable, monitor ECG and electrolytes closely and interrupt or reduce mobocertinib according to labeling for QTc prolongation.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Memantine-donepezil and Mobocertinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Memantine-donepezil with Mobocertinib?

MediHelp rates the interaction as major. Memantine-donepezil and Mobocertinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mobocertinib carries a boxed warning for QT prolongation and torsades de pointes, and donepezil adds further QT risk. The combination can cause life-threatening arrhythmia.

How serious is the interaction between Memantine-donepezil and Mobocertinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concomitant use where possible. If unavoidable, monitor ECG and electrolytes closely and interrupt or reduce mobocertinib according to labeling for QTc prolongation.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in